Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
261 SEK | +0.62% | +3.24% | -2.25% |
Mar. 14 | Certain Shares of Swedish Orphan Biovitrum AB are subject to a Lock-Up Agreement Ending on 14-MAR-2024. | CI |
Feb. 13 | Sobi to Expand in South Korea via Rare Disease JV with Handok | MT |
Business Summary
Number of employees: 1,772
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Haematology
60.4
%
| 10,831 | 57.6 % | 13,370 | 60.4 % | +23.44% |
Immunology
34.5
%
| 6,679 | 35.5 % | 7,635 | 34.5 % | +14.31% |
Specialty Care
5.1
%
| 1,280 | 6.8 % | 1,119 | 5.1 % | -12.58% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
36.8
%
| 7,364 | 39.2 % | 8,148 | 36.8 % | +10.65% |
Europe
35.5
%
| 3,585 | 19.1 % | 7,851 | 35.5 % | +119.00% |
Global
12.3
%
| 1,427 | 7.6 % | 2,718 | 12.3 % | +90.47% |
Rest of the World
12.0
%
| 2,438 | 13.0 % | 2,653 | 12.0 % | +8.82% |
Sweden
3.0
%
| 667 | 3.5 % | 660 | 3.0 % | -1.05% |
North America
0.4
%
| 77 | 0.4 % | 93 | 0.4 % | +20.78% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Guido Oelkers
CEO | Chief Executive Officer | 59 | 17-05-21 |
Henrik Stenqvist
DFI | Director of Finance/CFO | 57 | 18-07-19 |
Chief Tech/Sci/R&D Officer | - | - | |
Chief Tech/Sci/R&D Officer | 49 | 09-12-31 | |
Sven Ullman
BRD | Director/Board Member | 68 | 20-12-31 |
Pablo de Mora
SAM | Sales & Marketing | 56 | 18-12-31 |
Daniel Rankin
PRN | Corporate Officer/Principal | 44 | 16-12-31 |
Mahmood Ladha
PRN | Corporate Officer/Principal | 60 | 18-12-31 |
Norbert Oppitz
PRN | Corporate Officer/Principal | 57 | 17-10-01 |
Armin Reininger
PRN | Corporate Officer/Principal | 67 | 17-01-05 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Sven Ullman
BRD | Director/Board Member | 68 | 20-12-31 |
Annette Clancy
CHM | Chairman | 70 | 14-05-07 |
Staffan Schüberg
BRD | Director/Board Member | 55 | 19-12-31 |
Director/Board Member | 54 | 11-05-04 | |
Filippa Stenberg
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 1,621,178 | 0 | 1,621,178 ( 100.00 %) | 50.87 % |
Stock B | 1 | 354,358,946 | 181,073,188 ( 51.10 %) | 14,601,832 ( 4.121 %) |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
14,436,902 | 4.07% | 360,767,353 $ |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.34% | 8.07B | |
-5.99% | 84.46B | |
+3.95% | 40.85B | |
-26.37% | 27.69B | |
+50.76% | 24.28B | |
-6.59% | 17.09B | |
-32.37% | 13.67B | |
-10.45% | 11.79B | |
-15.88% | 11.86B | |
+0.53% | 7.51B |
- Stock Market
- Equities
- SOBI Stock
- Company Swedish Orphan Biovitrum AB